Cablivi(Caplacizumab-yhdp)

Cablivi is a vWF-directed antibody fragment used to treat adult individuals with acquired thrombotic thrombocytopenic purpura (aTTP), in conjunction with immunosuppressive therapy and plasma exchange.

Recommended Dosage: Cablivi injection should be given upon beginning of plasma exchange therapy. The recommended dosage of Cablivi injection is as follows:

• First day of therapy: Cablivi 11 mg given via bolus IV injection at least 15 minutes prior to plasma exchange followed by Cablivi 11 mg given via SC injection after plasma exchange on day 1st.
  
• Subsequent days of therapy during daily plasma exchange: Cablivi 11 mg given via SC injection once a day after plasma exchange.
  
• Therapy following plasma exchange period: Cablivi 11 mg administered via SC injection once a day continuing for one month following the final daily plasma exchange. If after the initial therapy course, sign(s) of persistent underlying disease present, therapy may be extended for at least 28 days.
  
• Discontinue Cablivi 11 mg treatment in case the respective patient experiences excess than a couple of recurrences of acquired thrombotic thrombocytopenic purpura, while on therapy with Cablivi. 
  

• Severe bleeding may occur; risk is increased in those with underlying coagulopathies. In case of clinically significant bleeding, interrupt Cablivi 11 mg injection treatment. Withhold treatment 7 days before elective surgery, dental procedures, or any other invasive interventions. 
  
• Use of Cablivi is restricted in those with known severe hypersensitivity reactions to this medicine or to any of the existing excipients. Hypersensitivity reactions have included urticaria.
  
• Follow your health specialist’s instructions about using Caplacizumab-yhdp during pregnancy. This medicine may be responsible for increasing the risk of bleeding in both mother and baby.
  

What documents are required to import CABLIVI to India?

CABLIVI (caplacizumab-yhdp) injections can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patients ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from Doctor
  
• Import permit if applicable
  

Is CABLIVI available in India?

CABLIVI (caplacizumab-yhdp injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.

CABLIVI can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of CABLIVI (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Cablivi injection price in India. 

We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network is able to source the CABLIVI (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.